Four and half years since medical cannabis was made legal in the UK, a group of leading scientists is asking why patients with chronic pain, PTSD and anxiety — which could include upwards of 15 million people — still cannot access these legal medicines without expensive private prescriptions.
They also question whether a wealth of evidence on the drugs’ effectiveness is being ignored, due to prejudiced views of cannabis and a fear of being ‘being soft on drugs’...
Yet the government’s own data shows that only a handful of people in the UK (around 4) are receiving an NHS prescription. In addition, a Freedom of Information Request [3] revealed that no data had been collected by the NHS into the drugs’ value since legalisation — even though this was requested by the government’s own Advisory Council.[4]
“It begs the question, are they stalling a decision because of long standing prejudice and misunderstanding about these medicines? Are they simply ‘scared’ of cannabis?” says Prof David Nutt — the chair of Drug Science and an internationally respected neuropsychopharmacologist, who has spent decades researching drugs that affect the brain...
Article